Features of the course and modern diagnosis of chronic heart failure on the background of comorbid associations
https://doi.org/10.25789/YMJ.2019.68.27
Abstract
The literature review presents current information on the course of chronic heart failure (CHF) against the background of comorbid associations. Special attention is paid to modern methods of diagnosis of morphofunctional parameters of the myocardium, the importance of immunological status, prognosis.
About the Authors
A. S. Ankudinov
Irkutsk State Medical University
Russian Federation
Russian Federation
Ankudinov Andrey Sergeevich – PhD, Associate Professor of the Department of Simulation Technologies and Emergency Medical Aid
Irkutsk, 89140107928
A. N. Kalyagin
Irkutsk State Medical University
Russian Federation
Russian Federation
Kalyagin Alexey Nikolaevich – doctor of medical sciences, professor, head of the department of propedeutics of internal diseases
Irkutsk, 89643521678
References
1. Ankudinov A.S. Evaluation of the basic clinical parameters of chronic heart failure in women with rheumatoid arthritis (preliminary data) / А.S. Ankudinov, A.N. Kalyagin // Zabaikalsky Medical Vestnik. - 2018. – Vol.3. - p. 93-98.
2. Efremova E.V. The problem of comorbidity in chronic heart failure / E.V. Efremova, A.M. Shutov, E.O. Borodulina // Ulyanovsk medical-biological Journal. - 2015. - 4. - P.46-52.
3. Cardiorenal syndrome in chronic heart failure: pathogenesis, diagnosis, prognosis and treatment options / Y.A. Medvedeva, N.V. Shilyaeva, E.N. Schukin [et al.] // Russian Journal of Cardiology. – 2017. - V.22, №1. - p. 136-141.
4. Cardiac oncology: modern aspects of prophylaxis of anthracycline cariodine toxicity / Yu.A. Vasiuk, E.L. Shkolnik, V.V. Nesvetov [et al.] // Cardiology. - 2016. - №12 (56). - pp.т72-79. doi: 10.18565/cardio.2016.12.72-79.
5. Comorbid pathology in clinical practice. Clinical recommendations / R.G. Oganov, I.N. Denisov, V.I. Simanenkov [et al.] // Cardiovascular Therapy and Prevention. - 2017. - №16 (6). - P.5-56. doi: 10.15829 / 1728-8800-2017-6-5-56
6. Comorbid conditions in various types of cardiorenal syndrome in patients with chronic heart failure / S.Yu. Volkova, K.A. Tomashevich, N.A. Mamatulina [et al.] // Medical science and education of the Urals. - 2017. - V.18, №4. - P.13-17.
7. Nasonov E.L. Rheumatic diseases and multimorbidity / E.L. Nasonov, A.V. Gordeev, E.A. Galushko // Therapeutic archive. - 2015. №5. - p. 4-9.
8. Fomin I.V. Chronic heart failure in the Russian Federations: what we know today and what we should do / Russian Cardiology Journal // I.V. Fomin. - 2016. - T.8. - C.7-13. doi: 10.15829/1560-4071-2016-8-7-13.
9. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC / P. Ponikowski, A.A. Voors, S.D. Anker [et al.] // European Heart Journal. ‒ 2016. ‒ 37 (27): P.2129–200. doi:10.1093/eurheartj/ehw128.
10. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism / A. Huerta, B. Lopez, S. Ravassa [et al.] // J Hypertens. ‒ 2016 ‒ Vol. 34 (1). ‒ P.130-8.
11. Association of Pentraxin-3 with Autoimmune Diseases: A Systematic Review and Meta-Analysis. Arch Med Res / X.L. Huang, L. Zhang, Y. Duan [et al.] // J. Arcmed. ‒ 2016. ‒ Vol. 47(3). ‒ P. 223-31. doi: 10.1016/j.arcmed.2016.05.006.
12. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design and preliminary observations from the first 100 000 cases in the acute decompensated heart failure national registry (ADHERE) / K.F. Adams Jr, C.C. Fonarow [et al.] // Am Heart J. ‒ 2005. ‒ 149: P. 209-15.
13. Clinical Utility of Three B-Type Natriuretic Peptide Assays for the Initial Diagnostic Assessment of New Slow-Onset Heart Failure / J.C. Kelder, M.J. Cramer, W.M. Verweij // Journal of Cardiac Failure. ‒ 2011. ‒ Vol. 17 (9). ‒ P. 729–34. doi:10.1016/j.cardfail.2011.04.013.
14. Development of congestive heart failure in type 2diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2DIABetes, Hypertension, Cardiovascular Events and Ramipril) study // Diabetes Care. ‒ 2003. ‒ Vol. 26 (3): P.855-860.
15. Diabetes in heart failure: prevalence and impact on outcome in the population / A.M. From, C.L. Leibson, F. Bursi // Am. J. Med. – 2006. – 119 (7): P. 591-599.
16. Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity / S.F. Issa, A.F. Christensen, H.M. Lindegaard [et al.] // Scand J Immunol. ‒ 2017. ‒ Vol. 86(6). ‒ P. 471-478. doi: 10.1111/sji.12619.
17. Galectin-3, a potential therapeutic target for rheumatoid arthritis? / Q. Xie, M. Ni, S.C. Wang [et al.] // Scand J Immunol. ‒ 2018. ‒ Vol. 87 (2). ‒ P.108. doi: 10.1111/sji.12631.
18. Heart failure register: a valuable tool for improving the management of patients with heart falure / A. Jonsson, E. Magnus, A. Urban [et al.] // European Heart Journal. ‒ 2010. ‒ 12. P.25–31.
19. Mosterd A. Clinical epidemiology of heart failure / A. Mosterd, A.W. Hoes // Heart. ‒ 2007. ‒ 93 (9). P.1137–46. doi: 10.1136/hrt. 2003.025270
20. Nurmohamed M.T. Cardiovascular comor bidity in rheumatic disease / M.T. Nurmohamed, M. Heslinga, G.D. Kitas // Nat Rev Rheumatol. ‒ 2015. ‒11. P.693-704. doi:10.1038/nrrheum.2015.112
21. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure / S. Suzuki, Y. Takeishi, T. Niizeki [et al.] // Am Heart J. ‒ 2008. ‒ Vol. 155 (1). ‒ P.75–81. Association.
22. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular imaging / R.M. Lang, L.P. Badano, V. Mor-Avi [et al.] // Journal American Society Echocardiography. ‒ 2015. ‒ Vol. (28). – P. 1-39. doi:10.1016/j.echo.2014.10.003.
23. Relation of plasma levels of adiponectin to left ventricular diastolic dysfunction in patients undergoing cardiac catheterization for coronary artery disease / H. Fukuta, N. Ohte, K. Wakami [et al.] // Am J Cardiol. ‒ 2011. ‒ Vol. 15 (108). ‒ P. 1081–5.
24. The Global Economic Burden of Non communicable Diseases / D.E. Bloom, E.T. Cafiero, E. Jané-Llopis [et al.] // Geneva: World Economic Forum. – 2011.
25. The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction / R. Stahrenberg, F. Edelmann, M. Mende [et al.] // Eur J Heart Fail. ‒ 2010. ‒Vol. 12 (12). ‒ P. 1309–16.
26. Utility of biomarkers in the differential diagnosis of heart failure in older people: findings from the Heart Failure in Care Homes (HFinCH) diagnostic accuracy study / J.M. Mason, H.C. Hancock, H. Close [et al.] // PLoS One. ‒ 2013. ‒ Vol. 8 (1). ‒ P. 535-60. Recommenda
Review
For citations:
Ankudinov A.S., Kalyagin A.N. Features of the course and modern diagnosis of chronic heart failure on the background of comorbid associations. Yakut Medical Journal. 2019;(4):96-99. https://doi.org/10.25789/YMJ.2019.68.27
Views:
2
Email this article 